BiomedicalPublications

Therapeutic Advances in Chronic Disease

SAGE Publishing·United Kingdom·ISSN 2040-6223

Open accessIn DOAJFee waivers availableMedicine

Therapeutic Advances in Chronic Disease is published by SAGE Publishing as an open access journal (ISSN 2040-6223). The list article processing charge is $2,950. Typical time to publication is 12 wks. Its OpenAlex h-index is 69. Primary field: Medicine. It is listed in the Directory of Open Access Journals. Fee waivers are stated as available. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.

Cost to publish

$2,950

Open-access article processing charge, list price.

Checked · Journal fee page

Time to publication

12 wks

Broadly typical for the field.

h-index

69

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

4.0

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Therapeutic Advances in Chronic Disease is listed at $2,950. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in Therapeutic Advances in Chronic Disease, as recorded by OpenAlex for each year. The fee has risen 34% since 2019, from $2,200 to $2,950.

$0$1.5k$3k2019: $2,20020192020: $2,20020202021: $2,40020212022: $2,30020222023: $2,30020232024: $2,9502024

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY, CC BY-NC
Author keeps copyrightNo
Plagiarism screeningYes
Editorial boardPublished →
LanguagesEN

Verification checks

8 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredAnonymous peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2025.

Scope

The subjects Therapeutic Advances in Chronic Disease publishes most, derived from the topics assigned to its indexed articles.

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsRheumatoid Arthritis Research and TherapiesPsoriasis: Treatment and PathogenesisAsthma and respiratory diseasesSpondyloarthritis Studies and TreatmentsChronic Obstructive Pulmonary Disease (COPD) ResearchDiabetes Treatment and ManagementInflammatory Bowel DiseaseRespiratory and Cough-Related Research

Publication record

Indexed articles746
Total citations20,648
i10-index438
Most recent indexed article2025
Open access since2019
All ISSNs2040-6223, 2040-6231

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.